Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial

The role of extended pelvic lymph node dissection (EPLND) in the surgical management of prostate cancer (PCa) patients remains controversial, mainly because of a lack of randomized controlled trials (RCTs).To determine whether EPLND has better oncological outcomes than limited PLND (LPLND.This was a prospective, single-center phase 3 trial in patients with intermediate- or high-risk clinically localized PCa.Randomization (1:1) to LPLND...